[New agent development for T-cell non-Hodgkin lymphoma: current status and future directions].
Kensei
K
Tobinai
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use; D006801:Humans; D016399:Lymphoma, T-Cell / Q000188:drug therapy*; D058990:Molecular Targeted Therapy
D000970:Antineoplastic Agents; D001688:Biological Products